Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$4.8B |
 |
Tempus AITEM |
-$7.45B |
 |
TeleflexTFX |
-$40M |
 |
Universal Health ServicesUHS |
-$43M |
 |
ProgynyPGNY |
-$1.08B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Whalen Kathleen M | Nov 14, 2024 | Sell | 1,474 | $357.99 | $530,000 |
| Billington Phillip G | Nov 14, 2024 | Sell | 3,897 | $350 | $1.4M |
| Akdamar Erol R | Nov 14, 2024 | Sell | 2,900 | $353 | $1M |
| Cuffe Michael S. | Sep 12, 2024 | Sell | 8,358 | $385.42 | $3.2M |
| Whalen Kathleen M | Jul 31, 2024 | Sell | 2,987 | $363.51 | $1.1M |
| Whalen Kathleen M | Jul 29, 2024 | Sell | 1,864 | $359.92 | $670,000 |
| Reiner Deborah M | Jul 29, 2024 | Sell | 3,314 | $359.9621 | $1.2M |
| Wyatt Christopher F. | Jul 29, 2024 | Sell | 4,000 | $360.1956 | $1.4M |
| Torres Kathryn A. | Jul 25, 2024 | Sell | 1,857 | $355.05 | $660,000 |
| Whalen Kathleen M | May 16, 2024 | Sell | 3,204 | $326.3 | $1M |
| Torres Kathryn A. | May 15, 2024 | Sell | 1,863 | $326.1799 | $610,000 |
| Cuffe Michael S. | May 9, 2024 | Sell | 6,311 | $316.8792 | $2M |
| Cohen Jeffrey E. | May 9, 2024 | Sell | 1,650 | $313 | $520,000 |
| Cuffe Michael S. | May 6, 2024 | Sell | 1,600 | $309 | $490,000 |
| Torres Kathryn A. | May 3, 2024 | Sell | 890 | $312 | $280,000 |
| Torres Kathryn A. | May 2, 2024 | Sell | 973 | $312 | $300,000 |
| Wasserman Chad J | Mar 20, 2024 | Sell | 876 | $330.25 | $290,000 |
| Wasserman Chad J | Mar 18, 2024 | Sell | 344 | $321.97 | $110,000 |
| RUTHERFORD BILL B | Feb 6, 2024 | Sell | 6,000 | $310.63 | $1.9M |
| Wyatt Christopher F. | Feb 5, 2024 | Sell | 4,000 | $312.42 | $1.2M |
| Mosier Sammie S | Feb 5, 2024 | Sell | 1,645 | $312 | $510,000 |
| Wasserman Chad J | Feb 2, 2024 | Sell | 652 | $312.0407 | $200,000 |
| Torres Kathryn A. | Jan 31, 2024 | Sell | 3,861 | $307 | $1.2M |
| Cuffe Michael S. | Jan 31, 2024 | Sell | 3,200 | $306.7918 | $980,000 |
| Torres Kathryn A. | Aug 14, 2023 | Sell | 5,204 | $269.1229 | $1.4M |
| Cohen Jeffrey E. | Aug 11, 2023 | Sell | 1,500 | $270 | $410,000 |
| Whalen Kathleen M | Aug 3, 2023 | Sell | 2,916 | $270 | $790,000 |
| Cuffe Michael S. | Apr 28, 2023 | Sell | 12,556 | $284.4374 | $3.6M |
| Akdamar Erol R | Apr 28, 2023 | Sell | 3,500 | $285 | $1,000,000 |
| Torres Kathryn A. | Apr 24, 2023 | Sell | 4,473 | $288.3776 | $1.3M |
| Paslick P. Martin | Apr 14, 2023 | Sell | 2,687 | $275 | $740,000 |
| Paslick P. Martin | Apr 10, 2023 | Sell | 2,539 | $270 | $690,000 |
| Paslick P. Martin | Apr 4, 2023 | Sell | 3,034 | $265 | $800,000 |
| Whalen Kathleen M | Feb 17, 2023 | Sell | 1,734 | $263.6083 | $460,000 |
| Berres Jennifer | Feb 7, 2023 | Sell | 4,000 | $255.228 | $1M |
| RUTHERFORD BILL B | Feb 3, 2023 | Sell | 30,000 | $258.1856 | $7.7M |
| Reiner Deborah M | Feb 3, 2023 | Sell | 7,941 | $257.6123 | $2M |
| Akdamar Erol R | Feb 2, 2023 | Sell | 3,000 | $258.6304 | $780,000 |
| Foster Jon M | Feb 1, 2023 | Sell | 16,424 | $251.9776 | $4.1M |
| Wyatt Christopher F. | Feb 1, 2023 | Sell | 4,900 | $253.3 | $1.2M |
| Paslick P. Martin | Feb 1, 2023 | Sell | 1,000 | $256.9487 | $260,000 |
| Cuffe Michael S. | Feb 1, 2023 | Sell | 4,000 | $257.1101 | $1M |
| McManus Timothy M | Jan 30, 2023 | Sell | 7,800 | $254.0522 | $2M |
| McManus Timothy M | Jan 30, 2023 | Sell | 100 | $254.6 | $25,000 |
What's the latest insider transaction for HCA Healthcare?
The most recent insider transaction for HCA Healthcare was conducted by Whalen Kathleen M, who sold 1,474 shares on November 14, 2024 at a price of $357.99 per share.
Which insider has sold the most HCA stock over the last two years?
Cuffe Michael S. has sold the most HCA stock in the last 2 years, with a total value of $11M.
What is the total value of insider transactions for HCA Healthcare (HCA) in the last 2 years?
The total value of insider transactions for HCA Healthcare in the last 2 years is negative, amounting to -$54M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on HCA Healthcare's market confidence?
Over the last 2 years, insider transactions for HCA Healthcare have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
